Listed

Design Therapeutics, Inc.

DSGNNasdaqCIK 1807120HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$22.2m, Q2 FY2026
Net income−$20.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-105062. Derived: 6-month figure less the 3-month figure.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-05, accession 0001193125-25-266970. Derived: 9-month figure less the 6-month figure.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-03, accession 0001193125-26-329579. Derived: 6-month figure less the 3-month figure.Report this figure
Research and development$m13.3Research and development, Q3 FY2023, three months to 2023-09-30$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure11.0Research and development, Q4 FY2023, three months to 2023-12-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0000950170-25-035910. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2024, three months to 2024-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure10.5Research and development, Q2 FY2024, three months to 2024-06-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure11.9Research and development, Q3 FY2024, three months to 2024-09-30$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure12.2Research and development, Q4 FY2024, three months to 2024-12-31$12.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure15.4Research and development, Q1 FY2025, three months to 2025-03-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure15.7Research and development, Q2 FY2025, three months to 2025-06-30$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure14.6Research and development, Q3 FY2025, three months to 2025-09-30$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure13.4Research and development, Q4 FY2025, three months to 2025-12-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure14.4Research and development, Q1 FY2026, three months to 2026-03-31$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure16.4Research and development, Q2 FY2026, three months to 2026-06-30$16.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Operating income$m(18.8)Operating income, Q3 FY2023, three months to 2023-09-30−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure(15.1)Operating income, Q4 FY2023, three months to 2023-12-31−$15.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-035910. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating income, Q1 FY2024, three months to 2024-03-31−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure(15.0)Operating income, Q2 FY2024, three months to 2024-06-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure(16.2)Operating income, Q3 FY2024, three months to 2024-09-30−$16.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure(16.7)Operating income, Q4 FY2024, three months to 2024-12-31−$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(20.4)Operating income, Q1 FY2025, three months to 2025-03-31−$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(21.6)Operating income, Q2 FY2025, three months to 2025-06-30−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure(19.3)Operating income, Q3 FY2025, three months to 2025-09-30−$19.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure(18.2)Operating income, Q4 FY2025, three months to 2025-12-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Operating income, Q1 FY2026, three months to 2026-03-31−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(22.2)Operating income, Q2 FY2026, three months to 2026-06-30−$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Net income$m(15.8)Net income, Q3 FY2023, three months to 2023-09-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure(11.8)Net income, Q4 FY2023, three months to 2023-12-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-035910. Derived: 12-month figure less the 9-month figure.Report this figure(11.1)Net income, Q1 FY2024, three months to 2024-03-31−$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure(11.8)Net income, Q2 FY2024, three months to 2024-06-30−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure(13.0)Net income, Q3 FY2024, three months to 2024-09-30−$13.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure(13.7)Net income, Q4 FY2024, three months to 2024-12-31−$13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(17.7)Net income, Q1 FY2025, three months to 2025-03-31−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(19.1)Net income, Q2 FY2025, three months to 2025-06-30−$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure(17.0)Net income, Q3 FY2025, three months to 2025-09-30−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure(16.0)Net income, Q4 FY2025, three months to 2025-12-31−$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Net income, Q1 FY2026, three months to 2026-03-31−$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(20.2)Net income, Q2 FY2026, three months to 2026-06-30−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Diluted EPS$ per share(0.28)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure(0.21)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure(0.23)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(0.34)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure(0.30)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(0.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Basic EPS$ per share(0.28)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figurenot reported(0.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure(0.21)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure(0.23)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figurenot reported(0.31)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(0.34)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure(0.30)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figurenot reported(0.29)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(0.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure

Balance sheet

Cash and equivalents$12.9m, Q2 FY2026
Shareholders' equity$201.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m27.9Cash and equivalents, Q3 FY2023, at 2023-09-30$27.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure21.2Cash and equivalents, FY2023, at 2023-12-31$21.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0000950170-25-035910.Report this figure29.4Cash and equivalents, Q1 FY2024, at 2024-03-31$29.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure45.7Cash and equivalents, Q2 FY2024, at 2024-06-30$45.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure30.3Cash and equivalents, Q3 FY2024, at 2024-09-30$30.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure22.6Cash and equivalents, FY2024, at 2024-12-31$22.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure13.7Cash and equivalents, Q1 FY2025, at 2025-03-31$13.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure19.7Cash and equivalents, Q2 FY2025, at 2025-06-30$19.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure15.1Cash and equivalents, Q3 FY2025, at 2025-09-30$15.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure16.9Cash and equivalents, FY2025, at 2025-12-31$16.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure12.8Cash and equivalents, Q1 FY2026, at 2026-03-31$12.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure12.9Cash and equivalents, Q2 FY2026, at 2026-06-30$12.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Current assets$m295Current assets, Q3 FY2023, at 2023-09-30$294.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure285Current assets, FY2023, at 2023-12-31$284.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0000950170-25-035910.Report this figure274Current assets, Q1 FY2024, at 2024-03-31$273.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure265Current assets, Q2 FY2024, at 2024-06-30$264.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure257Current assets, Q3 FY2024, at 2024-09-30$257.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure248Current assets, FY2024, at 2024-12-31$248.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure234Current assets, Q1 FY2025, at 2025-03-31$233.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure220Current assets, Q2 FY2025, at 2025-06-30$219.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure209Current assets, Q3 FY2025, at 2025-09-30$209.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure224Current assets, FY2025, at 2025-12-31$223.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure227Current assets, Q1 FY2026, at 2026-03-31$227.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure212Current assets, Q2 FY2026, at 2026-06-30$212.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Total assets$m300Total assets, Q3 FY2023, at 2023-09-30$299.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure290Total assets, FY2023, at 2023-12-31$289.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0000950170-25-035910.Report this figure279Total assets, Q1 FY2024, at 2024-03-31$278.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure270Total assets, Q2 FY2024, at 2024-06-30$269.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure262Total assets, Q3 FY2024, at 2024-09-30$261.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure252Total assets, FY2024, at 2024-12-31$252.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure237Total assets, Q1 FY2025, at 2025-03-31$237.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure223Total assets, Q2 FY2025, at 2025-06-30$222.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure212Total assets, Q3 FY2025, at 2025-09-30$211.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure226Total assets, FY2025, at 2025-12-31$226.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure230Total assets, Q1 FY2026, at 2026-03-31$230.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure215Total assets, Q2 FY2026, at 2026-06-30$215.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Current liabilities$m12.4Current liabilities, Q3 FY2023, at 2023-09-30$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure9.6Current liabilities, FY2023, at 2023-12-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0000950170-25-035910.Report this figure7.1Current liabilities, Q1 FY2024, at 2024-03-31$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure6.4Current liabilities, Q2 FY2024, at 2024-06-30$6.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure7.4Current liabilities, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure8.5Current liabilities, FY2024, at 2024-12-31$8.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure8.2Current liabilities, Q1 FY2025, at 2025-03-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure8.7Current liabilities, Q2 FY2025, at 2025-06-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure11.2Current liabilities, Q3 FY2025, at 2025-09-30$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure13.1Current liabilities, FY2025, at 2025-12-31$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure10.2Current liabilities, Q1 FY2026, at 2026-03-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure11.2Current liabilities, Q2 FY2026, at 2026-06-30$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Total liabilities$m14.9Total liabilities, Q3 FY2023, at 2023-09-30$14.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure12.0Total liabilities, FY2023, at 2023-12-31$12.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0000950170-25-035910.Report this figure9.2Total liabilities, Q1 FY2024, at 2024-03-31$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure8.3Total liabilities, Q2 FY2024, at 2024-06-30$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure9.2Total liabilities, Q3 FY2024, at 2024-09-30$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure10.0Total liabilities, FY2024, at 2024-12-31$10.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure9.6Total liabilities, Q1 FY2025, at 2025-03-31$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure9.8Total liabilities, Q2 FY2025, at 2025-06-30$9.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure12.1Total liabilities, Q3 FY2025, at 2025-09-30$12.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure13.7Total liabilities, FY2025, at 2025-12-31$13.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure12.4Total liabilities, Q1 FY2026, at 2026-03-31$12.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure13.3Total liabilities, Q2 FY2026, at 2026-06-30$13.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure
Shareholders' equity$m285Shareholders' equity, Q3 FY2023, at 2023-09-30$285.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure278Shareholders' equity, FY2023, at 2023-12-31$277.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001193125-26-098491.Report this figure270Shareholders' equity, Q1 FY2024, at 2024-03-31$269.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure261Shareholders' equity, Q2 FY2024, at 2024-06-30$261.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure252Shareholders' equity, Q3 FY2024, at 2024-09-30$252.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure242Shareholders' equity, FY2024, at 2024-12-31$242.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure228Shareholders' equity, Q1 FY2025, at 2025-03-31$227.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure213Shareholders' equity, Q2 FY2025, at 2025-06-30$213.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure200Shareholders' equity, Q3 FY2025, at 2025-09-30$199.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure213Shareholders' equity, FY2025, at 2025-12-31$212.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure218Shareholders' equity, Q1 FY2026, at 2026-03-31$218.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure202Shareholders' equity, Q2 FY2026, at 2026-06-30$201.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure

Cash flow

Operating cash flow−$15.5m, Q2 FY2026
Capital expenditure$21.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(14.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123349. Derived: 9-month figure less the 6-month figure.Report this figure(12.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0000950170-25-035910. Derived: 12-month figure less the 9-month figure.Report this figure(12.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure(11.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105062. Derived: 6-month figure less the 3-month figure.Report this figure(9.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266970. Derived: 9-month figure less the 6-month figure.Report this figure(9.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(14.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001193125-26-329579. Derived: 6-month figure less the 3-month figure.Report this figure(11.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266970. Derived: 9-month figure less the 6-month figure.Report this figure(12.0)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure(16.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure(15.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001193125-26-329579. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$53.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123349. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0000950170-25-035910. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$195.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105062. Derived: 6-month figure less the 3-month figure.Report this figure(0.0)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266970. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$87.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001193125-26-329579. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266970. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001193125-26-098491. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001193125-26-329579. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)62.51m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares55.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3055,782,329 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-062958.Report this figure55.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3155,908,033 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055788.Report this figure55.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3055,948,990 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0000950170-24-090337.Report this figure56.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3055,988,691 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123349.Report this figure56.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3156,488,527 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065643.Report this figure56.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3056,555,960 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105062.Report this figure56.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3056,620,731 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure56.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3156,757,827 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure56.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3056,859,388 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure57.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,950,999 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266970.Report this figure61.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3161,434,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-28, accession 0001193125-26-187063.Report this figure62.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3062,505,340 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure

Shares outstanding: 62.58mShares outstanding, period not labelled, at 2026-07-2962,581,651 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001193125-26-329579.Report this figure at Jul 29, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.